[Controlled observation on naoxuenin in treating 22 hypertensive encephalorrhagia patients].
42 cases of hypertensive encephalorrhagia (HER) were randomly divided into two groups. All cases received treatment within three days after the attack, group I received current conventional treatment as control, group II took 100ml Naoxuenin (NXN) oral liquid with conventional treatment. Effects were evaluated after 14-day treatment. Results indicated that NXN had direct therapeutic effect or/and synergistic effect on HER in acute phase, the mortality was significantly lowered (P < 0.05) and the recovery of nerve function speeded up in group II. And NXN displayed similar effect on different Syndromes and Types of the acute phase of HER (P > 0.05). Analysis of results of hemorheological examination of pre- and post-treatment suggested that NXN could improve the microcirculation and prevent the high hemo-viscosity syndrome caused by dehydration therapy.
Lu
Z Q
ZQ
Municipal Central Hospital, Xiangtan.
D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects; D002543:Cerebral Hemorrhage / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D012212:Rheology